Printer Friendly

Study Identifies Factors to Predict Survival After Liver Transplant.

A new model based on specific characteristics of liver donors and recipients may help predict survival after liver transplantation, according to a new study by physicians with the Veterans Affairs Puget Sound Health Care System in Seattle. Results are published in the November issue of Liver Transplantation.

"This model could be used to inform liver transplant candidates and their doctors what post-transplant survival would be expected when a given donor is offered and may be particularly helpful in marginal or high-risk donors," said George Ioannou, M.D., M.S., in a journal press release. Ioannou found that the donor age, cold ischemia time, recipient MELD score, and cause of liver disease have the greatest impact on survival.

However, the best model for patients without hepatitis C included donor age, cold ischemia time, gender, race/ethnicity, recipient age, BMI, MELD score, status at time of transplantation, diabetes mellitus, cause of liver disease, and serum albumin. For patients with hepatitis C, the best model included the same donor characteristics, and all recipient characteristics except cause of liver disease and serum albumin.

Link: (11/29/06)
COPYRIGHT 2006 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:medical research
Publication:Transplant News
Article Type:Brief article
Geographic Code:1USA
Date:Dec 1, 2006
Previous Article:Infection Prompts Recall of Donor Tissue.
Next Article:Mechanical Hearts May Prevent Need for Heart Transplant.

Related Articles
Iowa VA hospital ignores federal ban, considers HIV-positive vet for liver transplant.
Taiwan surgeons warn patients needing a liver transplant to avoid going to China because of low success rate.
Neisseria meningitidis endotoxin and capsule transmission by transplantation.
UCI liver transplant program closed following report 35 patients died on waitlist; CEO placed on leave.
UPMC School of Nursing to study factors predicting health outcomes of liver transplant recipients.
USC liver transplant program's high death rate to be investigated.
Y's Therapeutics initiates Phase II trial with YSPSL to prevent ischemic reperfusion injury in liver transplant patients.
UCI Medical Center's liver transplant program taken off probation by UNOS/OPTN board.
Advanced age doesn't appear to impact risk of death after liver transplant.
ViroPharma initiates Phase 3 study of maribavir in liver transplant patients.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters